News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘HeadNeckCancers’ clear

  • Dana-Farber researchers have received a three-year, $1.2 million research grant from Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation to lead a team in developing and testing new vaccines for patients with cancers linked to the human papillomavirus (HPV).

Tags: Grants, HeadNeckCancers, GynecologicCancers

  • A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2000 and 2009. The findings come from the latest Annual Report to the Nation on the Status of Cancer

Tags: CervicalCancer, Prevention, Survivorship, HeadNeckCancers, GynecologicCancers

  • Head and neck cancer expert Robert Haddad, MD, comments on the CDC's recommendation that boys should be vaccinated against the human papillomavirus (HPV).

Tags: CervicalCancer, Prevention, HeadNeckCancers, GynecologicCancers

  • Dana-Farber researchers, in collaboration with colleagues at other biomedical centers, have confirmed a new set of genetic mutations involved in head and neck squamous cell carcinoma.

Tags: HeadNeckCancers

  • Join Dana-Farber physician Dr. Robert Haddad for a half-hour live Twitter chat on Thursday, Sept. 16 to explore head and neck cancer risk, treatment, and prevention.

Tags: HeadNeckCancers

Showing 1-5 of 5 items